Ruxolitinib is a potent immunosuppressive compound: is it time for anti-infective prophylaxis?-Reference-Cited by-同舟云学术

Ruxolitinib is a potent immunosuppressive compound: is it time for anti-infective prophylaxis?

Published:2013-11-28 Issue:23 Volume:122 Page:3843-3844
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Heine Annkristin¹,Brossart Peter¹,Wolf Dominik¹

Affiliation:

1. Medical Clinic III for Oncology, Haematology and Rheumatology, University Hospital Bonn, Bonn, Germany

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/122/23/3843/1464799/3843.pdf

Reference9 articles.

1. Regulation of inflammatory responses in tumor necrosis factor-activated and rheumatoid arthritis synovial macrophages by JAK inhibitors.;Yarilina;Arthritis Rheum,2012

2. Preclinical evaluation of local JAK1 and JAK2 inhibition in cutaneous inflammation.;Fridman;J Invest Dermatol,2011

3. Reactivation of hepatitis B virus infection following ruxolitinib treatment in a patient with myelofibrosis [published online ahead of print August 9, 2013].;Caocci;Leukemia

4. An opportunistic infection associated with ruxolitinib, a novel janus kinase 1,2 inhibitor.;Wysham;Chest,2013

5. Bilateral toxoplasmosis retinitis associated with ruxolitinib.;Goldberg;N Engl J Med,2013

Cited by 141 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beyond the gut - Atypical presentation of Salmonella spp. infection;Acta Marisiensis - Seria Medica;2024-06-01

2. Acute invasive fungal sinusitis with orbital tip syndrome in patients on long-term use of ruxolitinib: a case report;Journal of Medical Case Reports;2024-04-05

3. Disseminated Histoplasmosis in a Patient with Myelofibrosis on Ruxolitinib: A Case Report and Review of the Literature on Ruxolitinib-Associated Invasive Fungal Infections;Journal of Fungi;2024-03-31

4. The CCR4/CCL17 axis drives intestinal acute Graft versus Host disease after allogeneic bone marrow transplantation;2024-03-06

5. Management of classical Philadelphia chromosome-negative myeloproliferative neoplasms in Asia: consensus of the Asian Myeloid Working Group;Clinical and Experimental Medicine;2023-09-25